names	level	sas.name	class	qc.tests	restrictions	units	description	MMRF.Source	DFCI_Source	DFCI2009_Source	UAMS_Source	sage.export
Patient	biallelicinactivation; blood; clinical; cnv; metadata; rnaseq; snv; translocations	Patient	character	column_exists; all_required	NA	NA	Normalized patient identification number. 	PER_PATIENT::PUBLIC_ID	Example: PD0000	example: DFCI_000_000AA	example: UAMS_0000	1
File_Name	biallelicinactivation; blood; cnv; metadata; rnaseq; snv; translocations	NA	character	column_exists; all_required	NA	NA	trimmed filename for uniquely matching study files	NA	NA	NA	NA	1
Study	metadata	Study	factor	column_exists; all_required	DFCI; DFCI.2009; LOHR; MMRF; UAMS	NA	Study cohort this patient belongs to	MMRF	DFCI	DFCI.2009	UAMS	1
Study_Phase	metadata	Study_Phase	character	column_exists	NA	NA	Study phase. So far this is only applicable to MMRF (eg. IA8, IA9)	Parsed from IA package structure	NA	NA	NA	1
Visit_Name	metadata	Visit_Name	character	column_exists	NA	NA	Text description of the visit type e.g. Baseline, Confirm Progression, etc.	Seq_QC_Summary.xlsx::Visits::Reason_For_Collection	NA	NA	NA	1
Sample_Name	metadata	Sample_Name	character	column_exists	NA	NA	Sample identifier. NOTE: this has been adjusted for MMRF from previous versions (e.g. was MMRF_0000_1). BM/PB was added to clarify ambiguous samples taken at the same visit point.	NA	NA	NA	NA	1
Sample_Type_Flag	metadata	Sample_Type_Flag	numeric	column_exists; all_required	0=Normal; 1=NotNormal	NA	Flag for Normal vs NotNormal sample type	NA	NA	NA	NA	1
Sample_Type	metadata	Sample_Type	character	column_exists; all_required	Normal; NotNormal	NA	Text descriptor for sample type	NA	NA	NA	NA	1
File_Name_Actual	metadata	NA	character	column_exists	NA	NA	Actual filename of sequencing file.	NA	NA	NA	NA	1
File_Path	metadata	NA	character	column_exists	NA	NA	s3 file path for file	NA	NA	NA	NA	0
Sequencing_Type	metadata	Sequencing_Type	character	column_exists; all_required	WES; WGS; RNA-Seq; Targeted	NA	What molecular technique was performed to generate this file.	MMRF_CoMMpass_IA9_Seq_QC_Summary.xlsx::MMRF_Release_Status	NA	NA	NA	1
Excluded_Flag	metadata	NA	numeric	column_exists	0=NotExcluded; 1=Excluded	NA	Flag from QC describing if this file should be excluded from further analysis.	MMRF_CoMMpass_IA9_Seq_QC_Summary.xlsx::MMRF_Release_Status	NA	NA	NA	0
Excluded_Specify	metadata	NA	character	column_exists	NA	NA	String description with details of why file was flagged for exclusion	MMRF_CoMMpass_IA9_Seq_QC_Summary.xlsx::MMRF_Release_Status	samples flagged in DFCI_WES_Cyto.xlsx	NA	NA	0
Disease_Status	metadata	Disease_Status	factor	column_exists; all_required	ND=NewDiagnosis; R=Relapse	NA	Simplified disease presentation status at sample collection, New diagnosis or Relapse	NA	NA	NA	NA	1
Tissue_Type	metadata	Tissue_Type	character	column_exists; all_required	PB; BM	NA	Source tissue derivation. PB=PeripheralBlood; BM=BoneMarrow	NA	NA	NA	NA	1
Cell_Type	metadata	Cell_Type	character	column_exists; all_required	CD138pos; PBMC	NA	Sample generated from selected cell type. PBMC=Peripheral Blood Mononuclear Cells; CD138pos=CD138 surface marker positive cells	NA	NA	NA	NA	1
NMF_Signature_Cluster	metadata	NA	factor	column_exists	A; B	NA	Non-negative matrix factorization (NMF) mutation signature group	NA	NA	NA	NA	0
Disease_Type	metadata	NA	character	column_exists; all_required	MM=”Multiple Myeloma”; PCL=”Plasma Cell Leukemia”	NA	What disease has this patient been diagnosed with. All samples from a patient are considered PCL if any CD138 selected PBMC samples were collected.	NA	NA	NA	NA	1
D_Gender	clinical	D_Gender	factor	column_exists	Male; Female	NA	Gender string	"recode(PER_PATIENT::D_PT_gender, ""Male"", ""Female"")"	NA	recode(Sex, 1=Male, 2=Female)	Gender column. M=Male; F=Female	1
D_Race	clinical	D_Race	factor	column_exists	ASIAN; AMERICANINDIAN; BLACKORAFRICAN; PACIFICISLANDER; WHITE; OTHER	NA	Race	"recode(PER_PATIENT::D_PT_race, ""WHITE"", ""BLACKORAFRICAN"", ""AMERICANINDIAN"", ""ASIAN"", ""NATIVEHAWAIIAN"", ""OTHER"")"	NA	NA	NA	1
D_Age	clinical	D_Age	numeric	column_exists; all_positive	NA	years	Age at diagnosis	PER_PATIENT.D_PT_age	NA	Age.at.diagnosis	Age column	1
D_Medical_History	clinical	D_Medical_History	character	column_exists	NA	NA	Specify. This field is not restricted to a curated set of responses, however specific values are flagged for an additional column in this table based on <MEDHX_conditions.of.interest.txt>	STAND_ALONE_MEDHX.medx	NA	NA	NA	1
D_Family_Cancer_History	clinical	D_Family_Cancer_History	character	column_exists	Yes; No	NA	Is there a family history of cancer?	STAND_ALONE_FAMHX.FAMHX_ISTHEREAFAMIL	NA	NA	NA	1
D_PrevBoneMarrowTransplant	metadata	D_PrevBoneMarrowTransplant	numeric	column_exists	0=no; 1=yes	NA	Has a bone marrow transplant been performed before the study day that this sample was collected?	PER-PATIENT-VISIT::VISITDY >= min(PER-PATIENT-VISIT::BMT_DAYOFTRANSPL for same PUBLIC_ID)	NA	NA	NA	1
Sample_Study_Day	metadata	Sample_Study_Day	numeric	column_exists; all_numeric	NA	NA	day of study that the sample was taken	NA	NA	NA	NA	1
TRT_1_trtgroup	clinical	TRT_1_trtgroup	numeric	column_exists	NA	NA	number of treatment groups administered during first line therapy	STAND_ALONE_TRTRESP::trtgroup	NA	NA	NA	0
TRT_1_therstdy	clinical	TRT_1_therstdy	numeric	column_exists; all_positive	NA	days	Study day of first line therapy start	STAND_ALONE_TRTRESP::trtstdy	NA	NA	NA	0
TRT_1_therendy	clinical	TRT_1_therendy	numeric	column_exists; all_positive	NA	days	Study day of first line therapy end	STAND_ALONE_TRTRESP::trtendy	NA	NA	NA	0
TRT_1_thername	clinical	TRT_1_thername	character	column_exists	NA	NA	Systematic therapy name. Individual drugs treatments within a treatment groups are combined by dash symbol. Sequentially administered treatment groups from first line therapy are joined in order of administration by semicolon. 	STAND_ALONE_TRTRESP::thername	NA	NA	NA	0
TRT_1_thershnm	clinical	TRT_1_thershnm	character	column_exists	NA	NA	Same as TRT_1_thername olumn with abbreviated drug names. For abbreviation mapping see s3://celgene.rnd.combio.mmgp.external/ClinicalData/ProcessedData/Resources/drug_name_abbreviation_table.txt	STAND_ALONE_TRTRESP::thershnm	NA	NA	NA	0
TRT_1_therclass	clinical	TRT_1_therclass	character	column_exists	NA	NA	Therapy class description	STAND_ALONE_TRTRESP::therclass	NA	NA	NA	0
TRT_1_bmtx_rec	clinical	TRT_1_bmtx_rec	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive a bone marrow transplant during first line treatment.	STAND_ALONE_TRTRESP::bmtx_rec	NA	NA	NA	0
TRT_1_bmtx_type	clinical	TRT_1_bmtx_type	character	column_exists	NA	NA	Description of bone marrow transplant type received during first line therapy. If multiple bmt were performed during first line therapy additional types are appended with semicolon	Simplify(STAND_ALONE_TRTRESP::bmtx_type)	NA	NA	NA	0
TRT_1_bmtx_n	clinical	TRT_1_bmtx_n	numeric	column_exists; all_positive	NA	NA	Number of bone marrow transplant the patient received during first line therapy.	max(STAND_ALONE_TRTRESP::bmtx_seq, na.rm = T)	NA	NA	NA	0
TRT_1_bmtx_day	clinical	TRT_1_bmtx_day	numeric	column_exists; all_positive	NA	NA	Study day of the  first bone marrow transplant received during first line therapy	min(STAND_ALONE_TRTRESP::bmtx_day, na.rm = T)	NA	NA	NA	0
TRT_1_bend	clinical	TRT_1_bend	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with bendamustine as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_bor	clinical	TRT_1_bor	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with bortezomib as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_car	clinical	TRT_1_car	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with carfilzomib as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_cyc	clinical	TRT_1_cyc	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with cyclophosphamide as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_dar	clinical	TRT_1_dar	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with daratumumab as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_dex	clinical	TRT_1_dex	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with dexamethasone as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_dox	clinical	TRT_1_dox	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with doxorubicin as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_doxlip	clinical	TRT_1_doxlip	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with liposomal doxorubicin as part of first line therapy.  	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_ixa	clinical	TRT_1_ixa	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with ixazomib as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_len	clinical	TRT_1_len	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with lenalidomide as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_mel	clinical	TRT_1_mel	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with melphalan as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_pom	clinical	TRT_1_pom	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with pomalidomide as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_pred	clinical	TRT_1_pred	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with prednisone as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_thal	clinical	TRT_1_thal	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with thalidomide as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_vin	clinical	TRT_1_vin	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with vincristine as part of first line therapy. 	STAND_ALONE_TREATMENT_REGIMEN::MMTX_THERAPY	NA	NA	NA	0
TRT_1_IMID	clinical	TRT_1_IMID	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive first line treatment that included Immunomodulatory imide drugs (IMiDs). This class of drugs includes: thalidomide, lenalidomide, pomalidomide and apremilast. This column is derived from as.numeric( TRT_1_thal | TRT_1_len | TRT_1_pom)	NA	NA	NA	NA	0
TRT_1_other	clinical	TRT_1_other	numeric	column_exists	0=no; 1=yes	NA	Did the patient receive treatment with a drug not specifically classified here (Other) as part of first line therapy. 	NA	NA	NA	NA	0
TRT_1_other_names	clinical	TRT_1_other_names	character	column_exists	NA	NA	List of other first line drug treatments not specifically classified	NA	NA	NA	NA	0
D_Diagnosis_Date	clinical	NA	date	column_exists	YYYY-mm-dd	NA	YYYY-mm-dd formatted diagnosis date	NA	NA	NA	NA	0
D_Relapse_Date	clinical	NA	date	column_exists	YYYY-mm-dd	NA	YYYY-mm-dd formatted date of first relapse	NA	NA	NA	NA	0
D_Death_Date	clinical	NA	date	column_exists	YYYY-mm-dd	NA	NA	NA	NA	NA	NA	0
D_Last_Visit_Date	clinical	NA	date	column_exists	YYYY-mm-dd	NA	YYYY-mm-dd formatted date of last visit	NA	NA	NA	NA	0
D_ISS	clinical	D_ISS	factor	column_exists	1; 2; 3	NA	International Staging System (ISS) criteria. 1=Stage I: Beta-2-macroglobulin < 3.5 mg/dL and albumin =3.5 g/dL; 2=Stage II: Neither stage I nor stage III; 3=Stage III: Beta-2-macroglobulin > 5.5 mg/L	PER_PATIENT.D_PT_iss	DFCI_WES_clinical_info_new.xlsx::ISS	2017-02-01_DFCI_RNASeq_Clinical.xls::ISS	ISS column. `Stage I` = 1, `Stage II` = 2, `Stage III` = 3	1
D_Response_Assessment	clinical	D_Response_Assessment	numeric	column_exists; all_numeric	NA	NA	Study day of latest response assessment.	max(PER-PATIENT-VISIT::AT_RESPONSEASSES, na.rm = T)	NA	NA	NA	1
D_Last_Visit	clinical	D_Last_Visit	numeric	column_exists; all_numeric	NA	NA	Study day of last visit. Does not require a progression assessment to have occurred.	max(PER-PATIENT-VISIT::VISITDY, na.rm = T)	NA	NA	NA	1
D_OS	clinical	D_OS	numeric	column_exists; all_positive	NA	days	Overall Survival time: time to death for those who died; time to last contact for those who are still alive.	STAND_ALONE_SURVIVAL::ttcos	DFCI_WES_clinical_info_new.xlsx::Days_survived	2017-02-01_DFCI_RNASeq_Clinical.xls::DiagToDeath	OS_months/12*365.25	1
D_OS_FLAG	clinical	D_OS_FLAG	numeric	column_exists	0=no; 1=yes	NA	Is the patient deceased? It turns out death day is a more consistent field for MMRF than the D_PT_DISCREAS flag, which was missing for a few patients that had a death date.	STAND_ALONE_SURVIVAL::censos	DFCI_WES_clinical_info_new.xlsx::Death	2017-02-01_DFCI_RNASeq_Clinical.xls::Death	OS_status	1
D_PFS	clinical	D_PFS	numeric	column_exists; all_positive	NA	days	Time to censored progression-free survivial (ttcpfs). From UAMS trial: Disease progression will be determined according to the Modified International Uniform Response criteria of Response and Progression (based on Blade et al, 1998; Durie et al, 2006; Rajkumar et al, 2011). Progression-free survival for induction chemotherapy comparisons is defined as the time from the date of initial randomisation to the trial to the date of  or dprogressioneath from any cause. Participants who do not progress will be censored at the last date they were known to be alive and progression-free. Participants discontinuing protocol treatment, receiving non-protocol treatment or suffering a second malignancy will still be followed for progression-free survival unless they explicitly withdraw consent. Progression-free survival for VCD randomisation comparisons is defined similarly from the date of VCD randomisation. Any participants who have been found to progress prior to entering the VCD randomisation will be censored at the date of VCD randomisation. Progression-free survival for maintenance randomisation comparisons is defined similarly from the date of maintenance randomisation. Any participants who have been found to progress prior to entering the maintenance randomisation will be censored at the date of maintenance randomisation.	STAND_ALONE_SURVIVAL::ttcpfs	DFCI_WES_clinical_info_new.xlsx::	2017-02-01_DFCI_RNASeq_Clinical.xls::DiagToRelapse	PFS_months/12*365.25	1
D_PFS_FLAG	clinical	D_PFS_FLAG	numeric	column_exists	0=no; 1=yes	NA	Flag for censored progression-free survivial. Has the patient been assessed for progressive disease or died from any cause.	STAND_ALONE_SURVIVAL::censpfs	DFCI_WES_clinical_info_new.xlsx::Relapse.1	2017-02-01_DFCI_RNASeq_Clinical.xls::Relapse	PFS_status	1
D_PD	clinical	D_PD	numeric	column_exists; all_positive	NA	NA	Time to first PD line 1	STAND_ALONE_SURVIVAL::ttfpd	NA	NA	NA	0
D_PD_FLAG	clinical	D_PD_FLAG	numeric	column_exists	0=no; 1=yes	NA	Flag if patient had a PD	STAND_ALONE_SURVIVAL::pdflag	NA	NA	NA	0
D_Cause_of_Death	clinical	D_Cause_of_Death	character	column_exists	NA	NA	Cause of death	PER_PATIENT.D_PT_CAUSEOFDEATH	NA	NA	NA	0
D_Reason_for_Discontinuation	clinical	D_Reason_for_Discontinuation	character	column_exists	NA	NA	Primary Reason for Discontinuation	PER_PATIENT.D_PT_PRIMARYREASON	NA	NA	NA	0
D_Discontinued	clinical	D_Discontinued	numeric	column_exists	0=no; 1=yes	NA	Study discontinuation flag	PER_PATIENT.D_PT_discont	NA	NA	NA	0
D_Complete	clinical	D_Complete	numeric	column_exists	0=no; 1=yes	NA	Study complete flag. Since the study is ongoing this only captures patients that have exited the study before completion. Those that are still enrolled are all reported as NA.	"recode(D_Complete::D_PT_complete, ""2"" = 0)"	NA	NA	NA	0
D_Best_Response_Code	clinical	D_Best_Response_Code	numeric	column_exists	1=CR, Complete Response; 2=sCR, Stringent Complete Response; 3=VGPR, Very Good Partial Response; 4=PR, Partial Response; 5=SD, Stable Disease; 6=PD, Progressive Disease	NA	Best observed therapy response from line 1 treatment regimen (numerically coded)	STAND_ALONE_TRTRESP.bestrespcd	NA	NA	NA	1
D_Best_Response	clinical	D_Best_Response	character	column_exists	NA	NA	Best observed therapy response from line 1 treatment regimen	STAND_ALONE_TRTRESP.bestresp	NA	NA	NA	1
CBC_Absolute_Neutrophil	blood	CBC_Absolute_Neutrophil	numeric	column_exists	NA	count x10^9/L	Absolute Neutrophil count	PER_PATIENT_VISIT.D_LAB_cbc_abs_neut	NA	NA	NA	1
CBC_Platelet	blood	CBC_Platelet	numeric	column_exists	NA	count x10^9/L	Platelet count. Observed range: 10-700 x10^9/L	PER_PATIENT_VISIT.D_LAB_cbc_platelet	NA	NA	NA	1
CBC_WBC	blood	CBC_WBC	numeric	column_exists	NA	count x10^9/L	White Blood Count	PER_PATIENT_VISIT.D_LAB_cbc_wbc	NA	NA	NA	1
DIAG_Hemoglobin	blood	DIAG_Hemoglobin	numeric	column_exists	NA	mmol/L	Hemogobin (mw=16 kg/mole). Observed Range: 2.7-10.2mmol/L. Convert g/dL * 0.625 = mmol/L	PER_PATIENT_VISIT.D_LAB_cbc_hemoglobin	NA	NA	NA	1
DIAG_Albumin	blood	DIAG_Albumin	numeric	column_exists	NA	g/L	Albumin. Observed range 16-54 g/L.	PER_PATIENT_VISIT.D_LAB_chem_albumin	NA	NA	Serum.albumin	1
DIAG_Calcium	blood	DIAG_Calcium	numeric	column_exists	NA	mmol/L	Calcium (mw=40.1 g/mole)	PER_PATIENT_VISIT.D_LAB_chem_calcium	NA	NA	Corrected.Calcium	1
DIAG_Creatinine	blood	DIAG_Creatinine	numeric	column_exists	NA	umol/L	Serum Creatinine (mw=113.12 g/mole)	PER_PATIENT_VISIT.D_LAB_chem_creatinine	NA	NA	Serum.creatinine	1
DIAG_LDH	blood	DIAG_LDH	numeric	column_exists	NA	ukat/L	LDH	PER_PATIENT_VISIT.D_LAB_chem_ldh	NA	NA	NA	1
DIAG_Beta2Microglobulin	blood	DIAG_Beta2Microglobulin	numeric	column_exists	NA	mcg/mL	Beta 2 Microglobulin. Obervsed range: 0.2-36 mcg/mL	PER_PATIENT_VISIT.D_LAB_serum_beta2_microglobulin	NA	NA	B2.microglobulin	1
CHEM_BUN	blood	CHEM_BUN	numeric	column_exists	NA	mmol/L	Blood Urea Nitrogen	PER_PATIENT_VISIT.D_LAB_chem_bun	NA	NA	NA	1
CHEM_Glucose	blood	CHEM_Glucose	numeric	column_exists	NA	mmol/L	Glucose	PER_PATIENT_VISIT.D_LAB_chem_glucose	NA	NA	NA	1
CHEM_Total_Protein	blood	CHEM_Total_Protein	numeric	column_exists	NA	g/dL	Total Protein	PER_PATIENT_VISIT.D_LAB_chem_totprot	NA	NA	NA	1
CHEM_CRP	blood	CHEM_CRP	numeric	column_exists	NA	mg/dL	C-Reactive Protein. Observed range 0-32 mg/dL.	PER_PATIENT_VISIT.D_LAB_serum_c_reactive_protein	NA	NA	NA	1
IG_IgL_Kappa	blood	IG_IgL_Kappa	numeric	column_exists	NA	mg/dL	Serum Kappa	PER_PATIENT_VISIT.D_LAB_serum_kappa	NA	NA	NA	0
IG_M_Protein	blood	IG_M_Protein	numeric	column_exists	NA	g/dL	Serum M Protein	PER_PATIENT_VISIT.D_LAB_serum_m_protein	NA	NA	NA	0
IG_IgA	blood	IG_IgA	numeric	column_exists	NA	g/L	Serum IgA	PER_PATIENT_VISIT.D_LAB_serum_iga	NA	NA	NA	0
IG_IgG	blood	IG_IgG	numeric	column_exists	NA	g/L	Serum IgG	PER_PATIENT_VISIT.D_LAB_serum_igg	NA	NA	NA	0
IG_IgL_Lambda	blood	IG_IgL_Lambda	numeric	column_exists	NA	mg/dL	Serum Lambda	PER_PATIENT_VISIT.D_LAB_serum_lambda	NA	NA	NA	0
IG_IgM	blood	IG_IgM	numeric	column_exists	NA	g/L	Serum IgM	PER_PATIENT_VISIT.D_LAB_serum_igm	NA	NA	NA	0
IG_IgE	blood	IG_IgE	numeric	column_exists	NA	mg/L	Serum IgE	PER_PATIENT_VISIT.D_LAB_serum_ige	NA	NA	NA	0
FLO_Markers	blood	FLO_Markers	numeric	column_exists	NA	NA	NA	NA	NA	NA	NA	0
FLO_Percent_Aneuploid	blood	FLO_Percent_Aneuploid	numeric	column_exists	NA	NA	Flow cytometer %aneuploidy population	NA	NA	NA	NA	0
FLO_IgH	blood	FLO_IgH	numeric	column_exists	NA	NA	NA	NA	NA	NA	NA	0
FLO_IgL	blood	FLO_IgL	numeric	column_exists	NA	NA	Light Chain by Flow	NA	NA	NA	NA	0
FLO_DNA_Index	blood	FLO_DNA_Index	numeric	column_exists	NA	NA	DNA Index. DNA content of cells is measured by the ability of propidium iodide to bind stoichiometrically to DNA.	NA	NA	NA	NA	0
MISC_BRAF_V600E	blood	MISC_BRAF_V600E	numeric	column_exists	0=no; 1=yes	NA	BRAF Status	NA	NA	NA	NA	0
MISC_ECOG_Status	blood	MISC_ECOG_Status	numeric	column_exists	0=Fully Active; 1=Restricted in physically strenuous activity; 2=Ambulatory and capable of all selfcare; 3=Capable of only limited selfcare; 4=Completely disabled	NA	Eastern Cooperative Oncology Group (ECOG) standard criteria for measuring how the disease impacts a patient?ˌ_s daily living abilities.	NA	NA	NA	NA	0
CYTO_Karyotype_FISH	translocations	CYTO_Karyotype_FISH	character	column_exists	NA	NA	Text description of karyotype	PER_PATIENT_VISIT.D_CM_KARYOTYPE	Karyotype	NA	NA	1
CYTO_t_4_14_FISH	translocations	CYTO_t_4_14__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR3	4;14 parsed from Karyotype	as.numeric(gsub(9, NA, t_4_14) )	Translocation_consensus == 4	1
CYTO_t_6_14_FISH	translocations	CYTO_t_6_14__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR4	NA	NA	Translocation_consensus == 6	1
CYTO_t_8_14_FISH	translocations	CYTO_t_8_14__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR5	NA	NA	MYC.translocation == t(8;14)	1
CYTO_t_11_14_FISH	translocations	CYTO_t_11_14__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR6	NA	NA	Translocation_consensus == 11	1
CYTO_t_12_14_FISH	translocations	CYTO_t_12_14__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR7	NA	NA	NA	1
CYTO_t_14_16_FISH	translocations	CYTO_t_14_16__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR8	14;16 parsed from Karyotype	NA	Translocation_consensus == 16	1
CYTO_t_14_20_FISH	translocations	CYTO_t_14_20__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR9	NA	NA	Translocation_consensus == 20	1
CYTO_MYC_FISH	translocations	CYTO_MYC_FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant involving MYC loci at chromosome 8 observed via FISH	NA	NA	NA	NA	1
CYTO_amp_1q_FISH	translocations	CYTO_amp_1q__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	NA	NA	1
CYTO_1qplus_FISH	translocations	CYTO_1qplus_FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	as.numeric(Gain_1q)	NA	1
CYTO_del_1p_FISH	translocations	CYTO_del_1p__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR12	NA	NA	NA	1
CYTO_del_1q_FISH	translocations	CYTO_del_1q__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR13	NA	NA	NA	1
CYTO_del_1p32_FISH	translocations	CYTO_del_1p32__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	NA	NA	1
CYTO_del_16q_FISH	translocations	CYTO_del_16q__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	del16q	NA	1
CYTO_del_17_17p_FISH	translocations	CYTO_del_17_17p__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_TRI_CF_ABNORMALITYPR2	dfci.cyto$Karyotype	NA	NA	1
CYTO_del_11q_FISH	translocations	CYTO_del_11q__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	NA	NA	1
CYTO_del_12p_FISH	translocations	CYTO_del_12p__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	NA	NA	1
CYTO_del_13q_FISH	translocations	CYTO_del_13q__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	NA	NA	1
CYTO_del_14q_FISH	translocations	CYTO_del_14q__FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	NA	NA	NA	NA	1
CYTO_Hyperdiploid_FISH	translocations	CYTO_Hyperdiploid_FISH	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Structural variant observed via FISH	PER_PATIENT_VISIT.D_CM_ANEUPLOIDYCAT, D_TRI_trisomies	Hyper parsed from Karyotype	NA	NA	1
CYTO_t_4_14_MANTA	translocations	CYTO_t_4_14__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_t_6_14_MANTA	translocations	CYTO_t_6_14__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_t_8_14_MANTA	translocations	CYTO_t_8_14__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_t_11_14_MANTA	translocations	CYTO_t_11_14__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_t_12_14_MANTA	translocations	CYTO_t_12_14__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_t_14_16_MANTA	translocations	CYTO_t_14_16__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_t_14_20_MANTA	translocations	CYTO_t_14_20__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_MYC_MANTA	translocations	CYTO_MYC_MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant involving MYC loci at chromosome 8 observed via FISH	NA	NA	NA	NA	0
CYTO_amp_1q_MANTA	translocations	CYTO_amp_1q__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_1qplus_MANTA	translocations	CYTO_1qplus_MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_del_1p_MANTA	translocations	CYTO_del_1p__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_del_1q_MANTA	translocations	CYTO_del_1q__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_del_1p32_MANTA	translocations	CYTO_del_1p32__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_del_16q_MANTA	translocations	CYTO_del_16q__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_del_17_17p_MANTA	translocations	CYTO_del_17_17p__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_del_11q_MANTA	translocations	CYTO_del_11q__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_del_13q_MANTA	translocations	CYTO_del_13q__MANTA	numeric	column_exists	0=no; 1=yes	NA	Structural variant observed via MANTA	NA	NA	NA	NA	0
CYTO_1qplus_ControlFreec	translocations	CYTO_1qplus_ControlFreec	numeric	column_exists	0=no; 1=yes	NA	NA	NA	NA	NA	NA	0
CYTO_Hyperdiploid_ControlFreec	translocations	CYTO_Hyperdiploid_ControlFreec	numeric	column_exists	0=no; 1=yes	NA	NA	NA	NA	NA	NA	0
CYTO_TETRAPLOID_ControlFreec	translocations	CYTO_TETRAPLOID_ControlFreec	numeric	column_exists	0=no; 1=yes	NA	NA	NA	NA	NA	NA	0
CYTO_t_4_14_CONSENSUS	translocations	CYTO_t_4_14__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_t_6_14_CONSENSUS	translocations	CYTO_t_6_14__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_t_8_14_CONSENSUS	translocations	CYTO_t_8_14__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_t_11_14_CONSENSUS	translocations	CYTO_t_11_14__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_t_12_14_CONSENSUS	translocations	CYTO_t_12_14__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_t_14_16_CONSENSUS	translocations	CYTO_t_14_16__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_t_14_20_CONSENSUS	translocations	CYTO_t_14_20__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_MYC_CONSENSUS	translocations	CYTO_MYC_CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_amp_1q_CONSENSUS	translocations	CYTO_amp_1q__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_1qplus_CONSENSUS	translocations	CYTO_1qplus_CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_del_1p_CONSENSUS	translocations	CYTO_del_1p__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_del_1q_CONSENSUS	translocations	CYTO_del_1q__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_del_1p32_CONSENSUS	translocations	CYTO_del_1p32__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_del_16q_CONSENSUS	translocations	CYTO_del_16q__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_del_17_17p_CONSENSUS	translocations	CYTO_del_17_17p__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_del_11q_CONSENSUS	translocations	CYTO_del_11q__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_del_13q_CONSENSUS	translocations	CYTO_del_13q__CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_Hyperdiploid_CONSENSUS	translocations	CYTO_Hyperdiploid_CONSENSUS	numeric	column_exists	0=no; 1=yes; 2=subclonal	NA	Consensus structural variant call	NA	NA	NA	NA	0
CYTO_Translocation_Consensus	translocations	CYTO_Translocation_Consensus	character	column_exists	4; 6; 8; 11; 16; 20	NA	Abbreviated column for which consensus multiple myeloma related translocation is present. ERROR2 is given when more than one translocation is reported in an individual consensus field. 	NA	NA	NA	NA	0
CYTO_Primary_Etiologic_Group	translocations	CYTO_PRIMARY_ETIOLOGIC_GROUP	numeric	column_exists	1=CCND1-11q13; 2=CCND3-6p21; 3=4p16, MMSET, t(4;14), FGFR3; 4=c-MAF with t(14;16), MAFB with t(14;20), MAFA with t(8;14); 5=D1 (+HRD, no translocations); 6=D1+D2; 7=D2 (+HRD, no translocations); 8=none	NA	Translocation category of clinically relevant structural changes.	NA	NA	NA	NA	0
BI_GENE_Flag	biallelicinactivation	NA	numeric	NA	0=NoInactivation; 1=Inactivation	NA	The biallelic inactivation matrix contains binary indicators of whether both copies of a designated gene are inactivated. A zero indicates no inactivation and a 1 indicates a mutation, deletion or homozygous deletion. Columns are named BI_GENE_Flag where GENE is a given gene symbol. NOTES: variant allele frequencies are not considered. regions where there are 2 or more mutations in the same gene are not checked. this table only includes results for genes and valid samples from the copy number table. data generated by Cody Ashby TCAshby@uams.edu	NA	NA	NA	NA	0
CNV_GENE_ControlFreec	cnv	NA	numeric	NA	0=deletion; 1=loss; 2=normal; -2=loh; 3=gain; 4=amplification	NA	The copy number matrix contains integer status indicators correspond to gene-level copy number status. 0 is a homozygous deletion, 1 is a loss, 2 is normal, -2 is copy number neutral loss of heterozygosity, 3 is a gain, 4 is amplification. Column are named CNV_GENE_ControlFreec where GENE is the corresponding hg19 gene symbol. This table only includes samples passing a three step criteria for filtering: 1.) t-test on regions of relative chromosomal stability (chromosome 2 and 10). If neither of them are normal (CN=2) than the sample fails. 2.) Median of the standard deviations of the data points across all chromosomes. If higher than 0.3, than the sample fails. 3.) If there are more than 600 CN segments, then the sample fails. data generated by Cody Ashby TCAshby@uams.edu	NA	NA	NA	NA	0
RNA_ENSG0000000000X.YY 	rnaseq	NA	numeric	NA	NA	NA	The RNA-Seq expression matrix contains floating point values of normalized RNA gene expression. Column are named RNA_ENSG0000000000X.YY where ENSG0000000000X is the corresponding Ensembl gene identifier and associate .YY version. Data generated by Mehmet_Samur@DFCI.HARVARD.EDU	NA	NA	NA	NA	0
SNV_GENE_BinaryConsensus	snv	NA	numeric	NA	0=no; 1=yes	NA	The SNV matrix contains binary indicators of whether a sample has any SNV/indel variants within a given gene. Zero values mean that gene does not contain any mutations, 1 it does. Columns are named SNV_GENE_BinaryConsensus where GENE is a given gene symbol. Individual variants were been previously filtered for various aspects to improve reliability. This binary table includes all variants (including silent mutations) listed on 20170213.snvsindels.filtered.metadata.ndmmonly.slim.txt which was generated by Chris Wardell CPWardell@uams.edu	NA	NA	NA	NA	0
SNV_total_ns_variants_n	metadata	NA	numeric	column_exists	NA	NA	Total number of variants excluding silent classes	NA	NA	NA	NA	0
SNV_ns_mutated_genes_n	metadata	NA	numeric	column_exists	NA	NA	Total number of genes with variants excluding silet classes	NA	NA	NA	NA	0
SNV_dbNSFP_Polyphen2_HDIV_pred_deleterious_variants_n	metadata	NA	numeric	column_exists	NA	NA	Total variant counts by PolyPhen-2  HumDiv classifier prediction	NA	NA	NA	NA	0
SNV_dbNSFP_Polyphen2_HVAR_pred_deleterious_variants_n	metadata	NA	numeric	column_exists	NA	NA	Total variant counts by PolyPhen-2 HumVar classifier prediction	NA	NA	NA	NA	0
SNV_dbNSFP_Polyphen2_HDIV_pred_deleterious_genes_n	metadata	NA	numeric	column_exists	NA	NA	Count of deleterious genes predicted by PolyPhen-2  HumDiv classifier	NA	NA	NA	NA	0
SNV_dbNSFP_Polyphen2_HVAR_pred_deleterious_genes_n	metadata	NA	numeric	column_exists	NA	NA	Count of deleterious genes predicted by PolyPhen-2 HumVar classifier	NA	NA	NA	NA	0
